Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

The summary for the Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed): This FOA provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological or neuromuscular disorders that fall under the NINDS mission. Therapeutic agents include small molecules, biologics or biotechnology-derived products. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network or other translational programs.
Federal Grant Title: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-21-122
Type of Funding: Grant
CFDA Numbers: 93.853
CFDA Descriptions: Information not provided
Current Application Deadline: February 20th, 2024
Original Application Deadline: February 20th, 2024
Posted Date: March 11th, 2021
Creation Date: March 11th, 2021
Archive Date: March 27th, 2024
Total Program Funding:
Maximum Federal Grant Award: $499,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: January 21st, 2022
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-21-122.html
Grant Announcement Contact
NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
• NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)
• Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VC...
• NINDS Child Neurology Career Development Program (CNCDP) (K12 - Clinical Trial Not Allowed...
• Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 C...
• The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed)
• NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
• NINDS Institutional Center Core Grants to Support Neuroscience Research
• Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health
• HIV/AIDS Clinical Trials Network Statistical and Data Management Centers (UM1 Clinical Tri...
• HIV/AIDS Clinical Trials Network Laboratory Centers (UM1 Clinical Trial Required)
• HIV/AIDS Clinical Trials Network Clinical Trials Units (UM1 Clinical Trial Required)
• HIV/AIDS Clinical Trials Network Leadership and Operations Centers (UM1 Clinical Trial Req...
• Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional D...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com